Phagocytic function in Down syndrome--I. Chemotaxis.

R M Barkin; W L Weston; J R Humbert; F Maire

doi:10.1111/j.1365-2788.1980.tb00078.x

Home/Archive/PubMed

PubMed · 6452528

Phagocytic function in Down syndrome--I. Chemotaxis.

R M Barkin·W L Weston·J R Humbert·F Maire

View original source ↗Export metadata ↓

Abstract

Defects in host defences may provide a partial explanation for the increased incidence of infection in individuals with Down syndrome. Neutrophil and monocyte cellular and humoral chemotaxis were evaluated to explore phagocytic function. Fourteen individuals with Down syndrome and fifteen matched institutionalised controls were studied. In addition, a non-matched comparison normal group was investigated, representing a non-institutionalised young adult population. Neutrophil chemotaxis in institutionalised individuals (both Down syndrome and matched controls) was significantly impaired. Monocyte chemotaxis in this group was lower than in comparison normals. Evaluation of humoral components of neutrophil chemotaxis revealed no significant differences between individuals with Down syndrome and those with no known chromosomal abnormality. Down syndrome subjects had diminished humoral monocyte chemotactic responses compared with institutionalised controls and normal subjects.

Explore related subjects

Chemotaxis, Leukocyte Down Syndrome Humans Monocytes Neutrophils Journal Article

Keep this discovery

Explore connections, maps & timelines

BibTeX RIS

R M Barkin, W L Weston, J R Humbert, F Maire. 1980. Phagocytic function in Down syndrome--I. Chemotaxis.. https://doi.org/10.1111/j.1365-2788.1980.tb00078.x

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2006

Synthesis, conformation and biological activity of centrally modified pseudopeptidic analogues of For-Met-Leu-Phe-OMe.

For-Met-betaAlapsi[CSNH]-Phe-OMe (3), For-Met-betaAlapsi[CH2NH]-Phe-OMe (5), For-Met-NH-pC6H4-SO(2-Phe-OMe 8a), For-Met-NH-mCH4-SO2-Phe-OMe (8b) and the corresponding N-Boc precursors (2, 4, 7a, b) have been synthesized and their activity towards human neutrophils has been evaluated in comparison with that shown by the reference tripeptide For-Met-Leu-Phe-OMe (fMLF-OMe). Chemotaxis, lysozyme release and superoxide anion production have been measured. (1)H NMR titration experiments and IR spectra have been discussed in order to ascertain the preferred solution conformation adopted by the tripeptide 3 with particular reference to the presence of a folded conformation centred at the centrally positioned thionated beta-residue.

Chemotaxis, Leukocyte↗

PubMed2006

Molecular mechanism of nitrogen mustard induced leukocyte(s) chemotaxis.

Nitrogen mustard(s) (NM) are the primary chemotherapeutic agents (Chlorambucil, BSO) that are used in treating the B-cell chronic lymphocyte leukemia (B-CLL). It is known that NM imparts oxidative stress by inducing the reactive oxygen species (ROS) and reactive nitrogen species (RNS) production in B-lymphocytes of B-CLL. It is likely that these nitrogen mustards can cause the oxidative stress in the peripheral blood leukocytes (PBL) of B-CLL patients. It is possible that chronic exposure of PBL to NM would induce drug resistance in B-CLL patients. However, the precise molecular mechanism(s) by which NM affect the PBL are not known at present. Here, an effort is made to present plausible mechanisms by which chronic NM exposure could lead to increased PBL chemotaxis and vascular tissue damage in B-CLL patients The clinical implication of this phenomenon is most likely the unwanted organ dysfunction in B-CLL patients. Identification of viable therapeutic targets to attenuate the PBL activation during the NM therapy would be beneficial for the clinical remission of B-CLL.

Chemotaxis, Leukocyte↗

PubMed2006

Intrauterine neutrophil activation is associated with pulmonary haemorrhage in preterm infants.

BACKGROUND: Clinical and experimental studies showing lung damage associated with biologically active neutrophil derivatives suggests the possibility that intrauterine neutrophil activation may predispose to the development of pulmonary haemorrhage in extremely low birthweight infants early after birth. OBJECTIVES: To assess neutrophil functional activity in cord blood from extremely low birthweight infants who subsequently developed severe pulmonary haemorrhage. METHODS: Neutrophil functional activity was evaluated in the cord blood of preterm neonates (gestational age <28 weeks and weight <800 g) who developed pulmonary haemorrhage (n = 6) and in controls who did not (n = 6). Infants with congenital abnormalities and noteworthy maternal complications such as diabetes, pre-eclampsia, haemorrhagic disorders, and connective tissue disease were excluded. Neutrophils isolated from cord blood immediately after delivery were tested to evaluate neutrophil chemotaxis, random motility, and chemiluminescence. Standard methodology was used. RESULTS: Chemotaxis and chemiluminescence of neutrophils from cord blood of infants with pulmonary haemorrhage was higher than in the controls (34.8 (2.0) v 28.6 (0.8) microm, p<0.001, and 95.8 (8.5) v 73.2 (3.6) cpm x10(3), p<0.001 respectively). Random motility of cord blood neutrophils was comparable in the two groups (28.6 (1.2) v 25.3 (1.2) microm, p<0.09). CONCLUSIONS: Intrauterine induction of chemotactic activity and metabolic oxygenation of neutrophils may predispose to the development of pulmonary haemorrhage in extremely low birthweight infants with respiratory distress early after birth.

Chemotaxis, Leukocyte↗